158 related articles for article (PubMed ID: 35129052)
1. Association between menopausal hormone therapy use and mortality risk: a Swedish population-based matched cohort study.
Simin J; Khodir H; Fornes R; Tamimi RM; Brusselaers N
Acta Oncol; 2022 May; 61(5):632-640. PubMed ID: 35129052
[TBL] [Abstract][Full Text] [Related]
2. Prediagnostic use of estrogen-only therapy is associated with improved colorectal cancer survival in menopausal women: a Swedish population-based cohort study.
Simin J; Liu Q; Wang X; Fall K; Williams C; Callens S; Engstrand L; Brusselaers N
Acta Oncol; 2021 Jul; 60(7):881-887. PubMed ID: 33861686
[TBL] [Abstract][Full Text] [Related]
3. Menopausal hormone therapies and risk of colorectal cancer: a Swedish matched-cohort study.
Liu Q; Simin J; Debelius J; Fall K; Sadr-Azodi O; Engstrand L; Williams C; Brusselaers N
Aliment Pharmacol Ther; 2021 Jun; 53(11):1216-1225. PubMed ID: 33857339
[TBL] [Abstract][Full Text] [Related]
4. Menopausal hormone therapy treatment options and ovarian cancer risk: A Swedish prospective population-based matched-cohort study.
Simin J; Tamimi RM; Callens S; Engstrand L; Brusselaers N
Int J Cancer; 2020 Jul; 147(1):33-44. PubMed ID: 31584190
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy and the risk of melanoma in post-menopausal women.
Hicks BM; Kristensen KB; Pedersen SA; Hölmich LR; Pottegård A
Hum Reprod; 2019 Dec; 34(12):2418-2429. PubMed ID: 31803923
[TBL] [Abstract][Full Text] [Related]
6. Menopausal hormone therapy and cancer risk: An overestimated risk?
Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
[TBL] [Abstract][Full Text] [Related]
7. Menopausal hormone therapy and the risk of esophageal and gastric cancer.
Brusselaers N; Maret-Ouda J; Konings P; El-Serag HB; Lagergren J
Int J Cancer; 2017 Apr; 140(7):1693-1699. PubMed ID: 28006838
[TBL] [Abstract][Full Text] [Related]
8. Menopausal hormone therapy and risk of sarcoidosis: a population-based nested case-control study in Sweden.
Dehara M; Kullberg S; Bixo M; Sachs MC; Grunewald J; Arkema EV
Eur J Epidemiol; 2024 Mar; 39(3):313-322. PubMed ID: 38212490
[TBL] [Abstract][Full Text] [Related]
9. Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy.
Magnusson C; Baron JA; Correia N; Bergström R; Adami HO; Persson I
Int J Cancer; 1999 May; 81(3):339-44. PubMed ID: 10209946
[TBL] [Abstract][Full Text] [Related]
10. Menopausal hormone therapy and risk of oesophageal adenocarcinoma in a population-based cohort study.
Xie SH; Santoni G; Lagergren J
Br J Cancer; 2022 Jan; 126(1):129-133. PubMed ID: 34671128
[TBL] [Abstract][Full Text] [Related]
11. Different menopausal hormone regimens and risk of breast cancer.
Brusselaers N; Tamimi RM; Konings P; Rosner B; Adami HO; Lagergren J
Ann Oncol; 2018 Aug; 29(8):1771-1776. PubMed ID: 29917061
[TBL] [Abstract][Full Text] [Related]
12. Menopausal hormone therapy and biliary tract cancer: a population-based matched cohort study in Sweden.
Kilander C; Lagergren J; Konings P; Sadr-Azodi O; Brusselaers N
Acta Oncol; 2019 Mar; 58(3):290-295. PubMed ID: 30656997
[TBL] [Abstract][Full Text] [Related]
13. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
[TBL] [Abstract][Full Text] [Related]
14. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
Norman RJ; Flight IH; Rees MC
Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
[TBL] [Abstract][Full Text] [Related]
15. Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study.
Cold S; Cold F; Jensen MB; Cronin-Fenton D; Christiansen P; Ejlertsen B
J Natl Cancer Inst; 2022 Oct; 114(10):1347-1354. PubMed ID: 35854422
[TBL] [Abstract][Full Text] [Related]
16. Long term hormone therapy for perimenopausal and postmenopausal women.
Marjoribanks J; Farquhar C; Roberts H; Lethaby A
Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
[TBL] [Abstract][Full Text] [Related]
17. Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74 years of age.
Li CI; Daling JR; Haugen KL; Tang MT; Porter PL; Malone KE
Breast Cancer Res Treat; 2014 Jun; 145(2):481-9. PubMed ID: 24748570
[TBL] [Abstract][Full Text] [Related]
18. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy in women with cancer and risk of cancer-specific mortality and cardiovascular disease: a protocol for a cohort study from Scotland and Wales.
McMenamin Ú; Hicks B; Hughes C; Murchie P; Hippisley-Cox J; Ranger T; Coupland C; Cardwell C
BMC Cancer; 2021 Mar; 21(1):313. PubMed ID: 33761919
[TBL] [Abstract][Full Text] [Related]
20. Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role?
Botteri E; Støer NC; Sakshaug S; Graff-Iversen S; Vangen S; Hofvind S; Ursin G; Weiderpass E
Int J Cancer; 2017 Nov; 141(9):1763-1770. PubMed ID: 28685818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
